BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 4356552)

  • 1. Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA).
    Hornykiewicz O
    Br Med Bull; 1973 May; 29(2):172-8. PubMed ID: 4356552
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine, extrapyramidal system, and psychomotor function.
    Papeschi R
    Psychiatr Neurol Neurochir; 1972; 75(1):13-48. PubMed ID: 4625495
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathophysiology of drug-induced dyskinesias.
    Korczyn AD
    Neuropharmacology; 1972 Sep; 11(5):601-7. PubMed ID: 4275111
    [No Abstract]   [Full Text] [Related]  

  • 4. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
    Degkwitz R
    Med Klin; 1969 Aug; 64(33):1451-6. PubMed ID: 4896563
    [No Abstract]   [Full Text] [Related]  

  • 5. L-Dopa and Parkinsonism.
    Calne DB; Sandler M
    Nature; 1970 Apr; 226(5240):21-4. PubMed ID: 4907560
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dopaminergic conception of Parkinsonism and its treatment with L-DOPA].
    Levin SL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(9):1418-26. PubMed ID: 4349303
    [No Abstract]   [Full Text] [Related]  

  • 7. Striatonigral degeneration. Response to levodopa therapy with pathological and neurochemical correlation.
    Sharpe JA; Rewcastle NB; Lloyd KG; Hornykiewicz O; Hill M; Tasker RR
    J Neurol Sci; 1973 Jul; 19(3):275-86. PubMed ID: 4716845
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-induced changes in brain dopamine and their relation to parkinsonism.
    Vogt M
    Sci Basis Med Annu Rev; 1970; ():276-91. PubMed ID: 4319923
    [No Abstract]   [Full Text] [Related]  

  • 9. Parkinson's disease: activity of L-dopa decarboxylase in discrete brain regions.
    Lloyd K; Hornykiewicz O
    Science; 1970 Dec; 170(3963):1212-3. PubMed ID: 5478194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The antipsychotic action of neuroleptics and basal ganglia function].
    Arushanian EB
    Farmakol Toksikol; 1973; 26(4):481-9. PubMed ID: 4151298
    [No Abstract]   [Full Text] [Related]  

  • 11. L-dihydroxyphenylalanine and its decarboxylase: new ideas on their neuroregulatory roles.
    Opacka-Juffry J; Brooks DJ
    Mov Disord; 1995 May; 10(3):241-9. PubMed ID: 7651438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic nervous transmission in Parkinson's disease.
    Rinne UK; Sonninen V; Riekkinen P; Laaksonen H
    Med Biol; 1974 Jun; 52(3):208-17. PubMed ID: 4371255
    [No Abstract]   [Full Text] [Related]  

  • 13. Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants.
    Von Voigtlander PF; Moore KE
    Neuropharmacology; 1973 May; 12(5):451-62. PubMed ID: 4145343
    [No Abstract]   [Full Text] [Related]  

  • 14. Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.
    Brogden RN; Speight TM; Avery GS
    Drugs; 1971; 2(4):262-400. PubMed ID: 4340597
    [No Abstract]   [Full Text] [Related]  

  • 15. Parkinson's disease: from brain homogenate to treatment.
    Hornykiewicz O
    Fed Proc; 1973 Feb; 32(2):183-90. PubMed ID: 4143953
    [No Abstract]   [Full Text] [Related]  

  • 16. L-dopa in Parkinsonism. A possible mechanism of action.
    Ng LK; Chase TN; Colburn RW; Kopin IJ
    Neurology; 1972 Jul; 22(7):688-96. PubMed ID: 4673250
    [No Abstract]   [Full Text] [Related]  

  • 17. [Functional and pathophysiological aspects of the basal ganglia].
    Yoshida M
    No To Hattatsu; 1984; 16(2):85-91. PubMed ID: 6145434
    [No Abstract]   [Full Text] [Related]  

  • 18. On the mechanism of the nullification of CNS effects of L-DOPA by pyridoxine in Parkinsonian patients.
    Pfeiffer R; Ebadi M
    J Neurochem; 1972 Sep; 19(9):2175-81. PubMed ID: 5072392
    [No Abstract]   [Full Text] [Related]  

  • 19. Dorsal hippocampal lesion does not affect dopaminergic indices in the basal ganglia.
    Lipska BK; Jaskiw GE; Karoum F; Phillips I; Kleinman JE; Weinberger DR
    Pharmacol Biochem Behav; 1991 Sep; 40(1):181-4. PubMed ID: 1664108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-O-methyldopa blocks dopa metabolism in rat corpus striatum.
    Reches A; Fahn S
    Ann Neurol; 1982 Sep; 12(3):267-71. PubMed ID: 7137962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.